Company
United StatesPublic company, NASDAQ: ARDXArdelyx, Inc. (NASDAQ: ARDX), Fremont, CA – FDA Inspections
Inspection records and compliance data for Ardelyx, Inc. in Fremont, California. 2 FDA inspections on record, 1 Form 483, last inspected July 24, 2023. Publicly traded as NASDAQ: ARDX.
Company Profile
This profile covers Ardelyx, Inc. based in Fremont, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected March 12, 2019. Last inspected July 24, 2023.
Most cited issue areas
- Failure to develop written procedures1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 24, 2023 | VAI | Human Drugs · Bioresearch Monitoring | 1210671 |
| March 12, 2019 | NAI | Human Drugs · Bioresearch Monitoring | 1083980 |
FDA documents
Form 483s (1)
Other FDA documents (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Ardelyx, Inc.
Stock ticker
ARDX
Exchange
NASDAQ
Share price
$3.12
Market cap
$784.3M
Price as of
November 13, 2026
FEI Number
3010169178
Address
34175 Ardenwood Blvd Ste 200, Fremont, California 94555, United States
Country
United States
ID: ca34caa9-3440-4e27-a0d0-177a42cc469e